GARDEN CITY, N.Y.--(BUSINESS WIRE)--ImaCor, Inc., the developer of the world’s only hemodynamic transesophageal echocardiography (hTEE™) technology, will be showcasing Zura EVO1™, its all-in-one platform for advanced hemodynamic management at three annual scientific meetings this month: EAST (Eastern Association for the Surgery of Trauma), SCCM (Society of Critical Care Medicine), and STS (Society of Thoracic Surgeons). This marks the premier demonstration of the enhanced platform, a first-of-its-kind for hemodynamic management. The new capabilities are imaging features at 7 MHz and 18 cm depth, hemodynamic trending data of cardiac filling and function, and availability of a transthoracic echocardiography (TTE) probe for complementary hemodynamic management.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
